U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT07569744) titled 'Resveratrol for Endothelial Dysfunction and Metabolic Control in Type 2 Diabetes' on April 29.
Brief Summary: Type 2 diabetes mellitus is associated with endothelial dysfunction, which contributes to increased cardiovascular risk. Chronic hyperglycemia induces oxidative stress and reduces nitric oxide bioavailability, leading to impaired endothelial function. Resveratrol, a natural polyphenol with antioxidant and anti-inflammatory properties, has been shown to improve endothelial function in experimental studies.
This randomized controlled trial aims to evaluate the effectiveness of resveratrol supplementation in improving endothelia...